TrialEmerging microbes & infections2025

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.

Simon Valayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.